251 related articles for article (PubMed ID: 31267709)
21. AML suppresses hematopoiesis by releasing exosomes that contain microRNAs targeting c-MYB.
Hornick NI; Doron B; Abdelhamed S; Huan J; Harrington CA; Shen R; Cambronne XA; Chakkaramakkil Verghese S; Kurre P
Sci Signal; 2016 Sep; 9(444):ra88. PubMed ID: 27601730
[TBL] [Abstract][Full Text] [Related]
22. microRNA-1246-containing extracellular vesicles from acute myeloid leukemia cells promote the survival of leukemia stem cells via the LRIG1-meditated STAT3 pathway.
Chen L; Guo Z; Zhou Y; Ni J; Zhu J; Fan X; Chen X; Liu Y; Li Z; Zhou H
Aging (Albany NY); 2021 Apr; 13(10):13644-13662. PubMed ID: 33893245
[TBL] [Abstract][Full Text] [Related]
23. Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.
Horiguchi H; Kobune M; Kikuchi S; Yoshida M; Murata M; Murase K; Iyama S; Takada K; Sato T; Ono K; Hashimoto A; Tatekoshi A; Kamihara Y; Kawano Y; Miyanishi K; Sawada N; Kato J
Haematologica; 2016 Apr; 101(4):437-47. PubMed ID: 26802051
[TBL] [Abstract][Full Text] [Related]
24. The leukemic stem cell niche: current concepts and therapeutic opportunities.
Lane SW; Scadden DT; Gilliland DG
Blood; 2009 Aug; 114(6):1150-7. PubMed ID: 19401558
[TBL] [Abstract][Full Text] [Related]
25. ICAM-1 Deficiency in the Bone Marrow Niche Impairs Quiescence and Repopulation of Hematopoietic Stem Cells.
Liu YF; Zhang SY; Chen YY; Shi K; Zou B; Liu J; Yang Q; Jiang H; Wei L; Li CZ; Zhao M; Gabrilovich DI; Zhang H; Zhou J
Stem Cell Reports; 2018 Jul; 11(1):258-273. PubMed ID: 29937143
[TBL] [Abstract][Full Text] [Related]
26. Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors.
Chandran P; Le Y; Li Y; Sabloff M; Mehic J; Rosu-Myles M; Allan DS
Leuk Res; 2015 Apr; 39(4):486-93. PubMed ID: 25703353
[TBL] [Abstract][Full Text] [Related]
27. Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment.
Selleri C; Montuori N; Salvati A; Serio B; Pesapane A; Ricci P; Gorrasi A; Li Santi A; Hoyer-Hansen G; Ragno P
Oncotarget; 2016 Sep; 7(37):60206-60217. PubMed ID: 27517491
[TBL] [Abstract][Full Text] [Related]
28. Niche-directed therapy in acute myeloid leukemia: optimization of stem cell competition for niche occupancy.
Patel SA; Dalela D; Fan AC; Lloyd MR; Zhang TY
Leuk Lymphoma; 2022 Jan; 63(1):10-18. PubMed ID: 34407733
[TBL] [Abstract][Full Text] [Related]
29. Digitalization of a non-irradiated acute myeloid leukemia model.
Li R; Cheng H; Cheng T; Liu L
BMC Syst Biol; 2016 Aug; 10 Suppl 3(Suppl 3):64. PubMed ID: 27585558
[TBL] [Abstract][Full Text] [Related]
30. Clonal evolution of pre-leukemic hematopoietic stem cells precedes human acute myeloid leukemia.
Majeti R
Best Pract Res Clin Haematol; 2014; 27(3-4):229-34. PubMed ID: 25455271
[TBL] [Abstract][Full Text] [Related]
31. LepR+ niche cell-derived AREG compromises hematopoietic stem cell maintenance under conditions of DNA repair deficiency and aging.
Wu L; Lin Q; Chatla S; Amarachintha S; Wilson AF; Atale N; Gao ZJ; Joseph J; Wolff EV; Du W
Blood; 2023 Nov; 142(18):1529-1542. PubMed ID: 37584437
[TBL] [Abstract][Full Text] [Related]
32. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Endosteal Vascular Niche Remodeling Rescues Hematopoietic Stem Cell Loss in AML.
Duarte D; Hawkins ED; Akinduro O; Ang H; De Filippo K; Kong IY; Haltalli M; Ruivo N; Straszkowski L; Vervoort SJ; McLean C; Weber TS; Khorshed R; Pirillo C; Wei A; Ramasamy SK; Kusumbe AP; Duffy K; Adams RH; Purton LE; Carlin LM; Lo Celso C
Cell Stem Cell; 2018 Jan; 22(1):64-77.e6. PubMed ID: 29276143
[TBL] [Abstract][Full Text] [Related]
34. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
Lefort S; Maguer-Satta V
Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
[TBL] [Abstract][Full Text] [Related]
35. Diabetes impairs the interactions between long-term hematopoietic stem cells and osteopontin-positive cells in the endosteal niche of mouse bone marrow.
Chiba H; Ataka K; Iba K; Nagaishi K; Yamashita T; Fujimiya M
Am J Physiol Cell Physiol; 2013 Oct; 305(7):C693-703. PubMed ID: 23885062
[TBL] [Abstract][Full Text] [Related]
36. Secreted protein Del-1 regulates myelopoiesis in the hematopoietic stem cell niche.
Mitroulis I; Chen LS; Singh RP; Kourtzelis I; Economopoulou M; Kajikawa T; Troullinaki M; Ziogas A; Ruppova K; Hosur K; Maekawa T; Wang B; Subramanian P; Tonn T; Verginis P; von Bonin M; Wobus M; Bornhäuser M; Grinenko T; Di Scala M; Hidalgo A; Wielockx B; Hajishengallis G; Chavakis T
J Clin Invest; 2017 Oct; 127(10):3624-3639. PubMed ID: 28846069
[TBL] [Abstract][Full Text] [Related]
37. Gap Junctions in the Bone Marrow Lympho-Hematopoietic Stem Cell Niche, Leukemia Progression, and Chemoresistance.
Singh AK; Cancelas JA
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991829
[No Abstract] [Full Text] [Related]
38. Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia.
Le Y; Fraineau S; Chandran P; Sabloff M; Brand M; Lavoie JR; Gagne R; Rosu-Myles M; Yauk CL; Richardson RB; Allan DS
Stem Cell Rev Rep; 2016 Apr; 12(2):235-44. PubMed ID: 26649729
[TBL] [Abstract][Full Text] [Related]
39. The cell fate determinant Llgl1 influences HSC fitness and prognosis in AML.
Heidel FH; Bullinger L; Arreba-Tutusaus P; Wang Z; Gaebel J; Hirt C; Niederwieser D; Lane SW; Döhner K; Vasioukhin V; Fischer T; Armstrong SA
J Exp Med; 2013 Jan; 210(1):15-22. PubMed ID: 23277453
[TBL] [Abstract][Full Text] [Related]
40. Microenvironmental remodeling as a parameter and prognostic factor of heterogeneous leukemogenesis in acute myelogenous leukemia.
Kim JA; Shim JS; Lee GY; Yim HW; Kim TM; Kim M; Leem SH; Lee JW; Min CK; Oh IH
Cancer Res; 2015 Jun; 75(11):2222-31. PubMed ID: 25791383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
